JSKN033 in Chinese Subjects with Advanced Malignant Tumors

NCT06770881 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: JSKN033

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd